Low prices for HIV drugs are only one step forward

Comment

Peter A West. BMJ. 2004.

. 2004 Feb 7;328(7435):349-50.

doi: 10.1136/bmj.328.7435.349-d.

No abstract available

Comment on

New deal from the World Trade Organisation.
Pollock AM, Price D. Pollock AM, et al. BMJ. 2003 Sep 13;327(7415):571-2. doi: 10.1136/bmj.327.7415.571. BMJ. 2003. PMID: 12969897 Free PMC article. No abstract available.

Glaxo drops drug prices, AIDS foundation drops suit.
[No authors listed] [No authors listed] AIDS Policy Law. 2003 May 23;18(10):6. AIDS Policy Law. 2003. PMID: 12809097 No abstract available.
Drugs should be affordable to India's poor to fight HIV/AIDS.
Agoramoorthy G, Hsu MJ. Agoramoorthy G, et al. AIDS. 2006 Oct 3;20(15):1988-9. doi: 10.1097/01.aids.0000247126.42753.b8. AIDS. 2006. PMID: 16988526 No abstract available.
Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
James JS. James JS. AIDS Treat News. 2001 Feb 28;(361):5-7. AIDS Treat News. 2001. PMID: 12765151
Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
Calmy A, Klement E, Teck R, Berman D, Pécoul B, Ferradini L. Calmy A, et al. AIDS. 2004 Dec 3;18(18):2353-60. AIDS. 2004. PMID: 15622311 Review. No abstract available.
A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S, Antunes OA, Fortunak JM. Pinheiro Edos S, et al. Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2. Antiviral Res. 2008. PMID: 18571246 Review.

1. Pollock M, Price D. New deal from the World Health Organization. BMJ 29003;327: 571. (13 September.) - PubMed